<bill session="117" type="hr" number="1107" updated="2023-06-15T21:30:32Z">
  <state datetime="2022-05-11">REFERRED</state>
  <status>
    <introduced datetime="2022-05-11"/>
  </status>
  <introduced datetime="2022-05-11"/>
  <titles>
    <title type="display">Designating the week of May 1, 2022, through May 7, 2022, as "Tardive Dyskinesia Awareness Week".</title>
    <title type="official" as="introduced">Designating the week of May 1, 2022, through May 7, 2022, as "Tardive Dyskinesia Awareness Week".</title>
  </titles>
  <sponsor bioguide_id="P000608"/>
  <cosponsors/>
  <actions>
    <action datetime="2022-05-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-05-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="sr" number="184" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Commemorative events and holidays"/>
    <term name="Drug therapy"/>
    <term name="Health promotion and preventive care"/>
    <term name="Mental health"/>
    <term name="Neurological disorders"/>
  </subjects>
  <amendments/>
  <summary date="2022-08-09T18:42:48Z" status="Introduced in House">This resolution supports the designation of Tardive Dyskinesia Awareness Week. Tardive dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities. It is caused by prolonged use of certain medications, including ones used to treat schizophrenia.</summary>
</bill>
